Flow Cytometer for Radioactive Samples

放射性样品流式细胞仪

• 批准号: 474414-2015
• 负责人: Hafeli, Urs
• 金额: $ 10.93万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Research Tools and Instruments - Category 1 (<$150,000)
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=564956
• 关键词: Flow; Cytometer; Radioactive; Samples

The purchase of the BD FACSVerse instrument, a flow cytometer designed to support cell analysis for biomedical research applications, is critical for the ongoing research of 9 labs at UBC. Installed in Dr. Hafeli's radiopharmaceutical lab in the new Pharmaceutical Sciences building, the instrument will be used to carry out flow cytometry of radioactive cells and particles, something that is currently not allowed at any other facility/ lab on campus. The Hafeli lab has extensive experience with all types of radioisotopes and has the permits to house the instrument. This highly sensitive instrument will provide a unique capability which is crucial not only in the development of the novel radiopharmaceuticals at UBC, the Cancer Agency, the Centre of Drug Research and Development (CDRD) and TRIUMF, but also in many biology, life sciences and engineering experiments.

购买BD FACSVerse仪器是一种旨在支持生物医学研究应用的细胞分析的流式细胞仪，对于UBC 9个实验室正在进行的研究至关重要。该仪器安装在Hafeli博士位于新制药科学大楼的放射性药物实验室中，将用于对放射性细胞和颗粒进行流式细胞术，这是目前校园内任何其他设施/实验室都不允许的。Hafeli实验室在所有类型的放射性同位素方面拥有丰富的经验，并拥有容纳该仪器的许可证。这种高灵敏度的仪器将提供一种独特的能力，这不仅对UBC，癌症机构，药物研究与开发中心（CDRD）和TRIUMF的新型放射性药物的开发至关重要，而且对许多生物学，生命科学和工程实验也至关重要。